Clinical outcomes of COVID-19 in Wuhan, China: a large cohort study
Research
[키워드] 95% CI
acute respiratory syndrome
Admission
antiviral drug
caused
Characteristics
clinical
cohort study
coronavirus
Coronavirus disease 2019
COVID-19
COVID-19 patient
D-dimer
death
demonstrated
described
Deterioration
develop
development
diabete
died
discharged
electronic medical record
elevated
feature
Final
Follow-up
glucocorticoid
greater
higher risk
illness onset
In-hospital
In-hospital death
increased the risk
independent risk factor
information
Inpatient
interquartile range
IQR
Laboratory
laboratory-confirmed
large cohort
Logistic regression
lymphocytopenia
mechanical ventilation
median age
Mortality
multivariable logistic regression
Non-invasive
non-survivor
oseltamivir
outbreak
outcome
Patient
patients with COVID-19
poor prognosis
predict
predictor
progression
reducing mortality
Result
retrospective
risk factor
Risk factors
risk of death
severe
severe COVID-19 patients
severe disease
Severe patient
severe patients
single-center
SOFA score
Spread
survivor
Treatment
was used
with COVID-19
Wuhan
Wuhan, China
[DOI] 10.1186/s13613-020-00706-3 PMC 바로가기 [Article Type] Research
[DOI] 10.1186/s13613-020-00706-3 PMC 바로가기 [Article Type] Research